About OJO | Search | Ahead of print | Current Issue | Archives | Author Instructions | Reviewer Guidelines | Online submissionLogin 
Oman Journal of Ophthalmology Oman Journal of Ophthalmology
  Editorial Board | Subscribe | Advertise | Contact
https://www.omanophthalmicsociety.org/ Users Online: 241  Wide layoutNarrow layoutFull screen layout Home Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

CASE REPORT

Intravitreal ranibizumab as salvage therapy in an extremely low-birth-weight infant with rush type retinopathy of prematurity

Lin Chun-Ju, Chen San-Ni, Hwang Jiunn-Feng

Year : 2012| Volume: 5| Issue : 3 | Page no: 184-186

   This article has been cited by
 
1 A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity
Emer T. Chang, Amandeep S. Josan, Ravi Purohit, Chetan K. Patel, Kanmin Xue
Ophthalmology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes
Marko M. Popovic, Prem Nichani, Rajeev H. Muni, Kamiar Mireskandari, Nasrin N. Tehrani, Peter J. Kertes
Survey of Ophthalmology. 2021; 66(4): 572
[Pubmed]  [Google Scholar] [DOI]
3 Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Tariq Aldebasi, MuatazA. Guma, Rabia Bashir, Saif AlSaif, WaleedA. Altwaijri, AbdulkareemM. AlBekairy
Medical Principles and Practice. 2019; 28(6): 526
[Pubmed]  [Google Scholar] [DOI]
4 Nonresponse and Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Treatment
Tsengelmaa Chuluunbat, R.V. Paul Chan, Nan-Kai Wang, Reyin Lien, Yen-Po Chen, An-Ning Chao, Kuan-Jen Chen, Tun-Lu Chen, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu
Ophthalmic Surgery, Lasers and Imaging Retina. 2016; 47(12): 1095
[Pubmed]  [Google Scholar] [DOI]
5 Intravitreal Anti-VEGF Therapy as a Treatment for Retinopathy of Prematurity: What We Know After 7 Years
Michael A. Klufas, R. V. Paul Chan
Journal of Pediatric Ophthalmology & Strabismus. 2015; 52(2): 77
[Pubmed]  [Google Scholar] [DOI]
6 Primary Intravitreal Ranibizumab for High-Risk Retinopathy of Prematurity
Caroline R. Baumal, Roger A. Goldberg, Jordana G. Fein
Ophthalmic Surgery, Lasers and Imaging Retina. 2015; 46(4): 432
[Pubmed]  [Google Scholar] [DOI]
7 Recent advances of medicine treatment research in retinopathy of prematurity
Zheng, L., Feng, G.-Q.
International. 2014; 14(3): 460-463
[Pubmed]  [Google Scholar]
8 Researches advance on anti-VEGF medication for retinopathy of prematurity
Zhao, H.-H., Huang, X.-L., Xie, S.-Z., Zhao, C.-H.
International. 2013; 13(12): 2421-2423
[Pubmed]  [Google Scholar]

 

Read this article